Novo Nordisk (GB:0TDD)
LSE:0TDD
Holding GB:0TDD?
Track your performance easily

Novo Nordisk (0TDD) Technical Analysis

10 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Novo Nordisk’s (0TDD) Moving Averages Convergence Divergence (MACD) indicator is 0.68, suggesting Novo Nordisk is a Sell.
Novo Nordisk’s (0TDD) 20-Day exponential moving average is 133.71, while Novo Nordisk’s (0TDD) share price is $137.268, making it a Buy.
Novo Nordisk’s (0TDD) 50-Day exponential moving average is 133.98, while Novo Nordisk’s (0TDD) share price is $137.268, making it a Buy.

Novo Nordisk (0TDD) Pivot Points

Aug 25, 2024, 12:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
133.88
135.00
136.14
137.26
138.40
139.52
140.66
Fibonacci
135.00
135.87
136.40
137.26
138.13
138.66
139.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Novo Nordisk (0TDD) Moving Averages

Aug 25, 2024, 12:13 AM
Period
Simple
Exponential
MA5
135.91Buy
136.07Buy
MA10
134.98Buy
134.78Buy
MA20
131.68Buy
133.71Buy
MA50
136.10Buy
133.98Buy
MA100
133.29Buy
131.70Buy
MA200
122.42Buy
122.33Buy
Novo Nordisk’s (0TDD) 10-Day exponential moving average is 134.78, while Novo Nordisk’s (0TDD) share price is $137.268, making it a Buy.
Novo Nordisk’s (0TDD) 100-Day exponential moving average is 131.70, while Novo Nordisk’s (0TDD) share price is $137.268, making it a Buy.
Novo Nordisk’s (0TDD) stock price is $137.268 and Novo Nordisk’s (0TDD) 50-day simple moving average is 136.10, creating a Buy signal.
Novo Nordisk’s (0TDD) stock price is $137.268 and Novo Nordisk’s (0TDD) 100-day simple moving average is 133.29, creating a Buy signal.
Novo Nordisk’s (0TDD) stock price is $137.268 and Novo Nordisk’s (0TDD) 200-day simple moving average is 122.42, creating a Buy signal.

Novo Nordisk (0TDD) Technical Indicators

Aug 25, 2024, 12:13 AM
Name
Value
Implied Action
RSI (14)
55.89
Neutral
STOCH (9,6)
89.85
Sell
STOCHRSI (14)
92.29
Sell
MACD (12,26)
0.68
Sell
ADX (14)
35.34
Neutral
Williams %R
-5.28
Sell
CCI (14)
111.70
Sell
ATR (14)
5.68
-
Ultimate Oscillator
78.18
Buy
ROC
10.21
Buy
Novo Nordisk’s (0TDD) Relative Strength Index (RSI) is 55.89, creating a Neutral signal.
Novo Nordisk’s (0TDD) Trend Strength Indicator (ADX) is 35.34, creating a Neutral signal.
Novo Nordisk’s (0TDD) Commodity Channel Index (CCI) is 111.70, creating a Sell signal.
Novo Nordisk’s (0TDD) Price Rate of Change (ROC) is 10.21, creating a Buy signal.

FAQ

Is 0TDD a Buy, Hold, or Sell?
Based on 0TDD’s technical indicators, 0TDD is a Buy.
    What is 0TDD’s RSI (14)?
    0TDD’s RSI (14) is 55.89, which suggests 0TDD is a Neutral.
      What is 0TDD’s MACD?
      0TDD’s MACD is 0.68, which suggests 0TDD is a Sell.
        What is 0TDD’s 5-day moving average?
        0TDD’s 5-day moving average is 135.91, which suggests 0TDD is a Buy.
          What is 0TDD’s 20-day moving average?
          0TDD 20-day moving average is 131.68, which suggests 0TDD is a Buy.
            What is 0TDD’s 50-day moving average?
            0TDD’s 50-day moving average is 136.10, which suggests 0TDD is a Buy.
              What is 0TDD’s 200-day moving average?
              0TDD’s 200-day moving average is 122.42, which suggests 0TDD is a Buy.
                What is 0TDD’s Williams % R (14)?
                0TDD’s Williams % R (14) is -5.28, which suggests 0TDD is a Sell.
                  What is 0TDD’s CCI (14)?
                  0TDD’s CCI (14) is 111.70, which suggests 0TDD is a Sell.
                    What is the share price of Novo Nordisk?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis